Ligand validation:8IRI

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRI_HTG_B_625	78%	34%	0.103	0.944	1.14	1.45	2	4	0	0	100%	1
8IRI_HTG_b_625	71%	37%	0.103	0.923	1.01	1.46	2	3	0	0	100%	1
8IRI_HTG_B_622	56%	29%	0.134	0.907	1.12	1.69	2	5	0	0	100%	1
8IRI_HTG_b_622	48%	24%	0.145	0.888	1.2	1.92	2	7	0	0	100%	1
8IRI_HTG_B_623	29%	41%	0.203	0.863	0.83	1.44	1	2	0	0	100%	1
8IRI_HTG_c_522	18%	37%	0.251	0.837	0.94	1.52	1	2	0	0	100%	1
8IRI_HTG_V_202	6%	57%	0.403	0.911	0.32	1.31	-	1	0	0	58%	0.5789
8IRI_HTG_C_522	6%	41%	0.349	0.773	0.89	1.39	1	1	0	0	100%	1
8IRI_HTG_d_410	5%	37%	0.314	0.764	0.91	1.54	1	1	0	0	84%	0.8421
8IRI_HTG_D_412	5%	34%	0.266	0.689	1.02	1.56	1	1	0	0	84%	0.8421
8IRI_HTG_b_623	2%	27%	0.452	0.69	1.06	1.84	1	2	0	0	100%	1
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	40%	0.092	0.971	1.13	1.22	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	37%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	35%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	45%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.